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Summary
Background: In eukaryotic cells, detectionof replication stress
results in the activation of the DNA replication checkpoint, a
signaling cascade whose central players are the kinases ATR
and Chk1. The checkpoint response prevents the accumula-
tion of DNA damage and ensures cell viability by delaying
progression into mitosis. However, the role and mechanism
of the replication checkpoint transcriptional response in
human cells, which is p53 independent, is largely unknown.
Results:We show that, in response to DNA replication stress,
the regular E2F-dependent cell-cycle transcriptional program
is maintained at high levels, and we establish the mechanisms
governing such transcriptional upregulation. E2F6, a repressor
of E2F-dependent G1/S transcription, replaces the activating
E2Fs at promoters to repress transcription in cells progressing
into S phase in unperturbed conditions. After replication
stress, the checkpoint kinase Chk1 phosphorylates E2F6,
leading to its dissociation from promoters. This promotes
E2F-dependent transcription, which mediates cell survival by
preventing DNA damage and cell death.
Conclusions: This work reveals, for the first time, that the
regular cell-cycle transcriptional program is part of the DNA
replication checkpoint response in human cells and estab-
lishes the molecular mechanism involved. We show that main-
taining high levels of G1/S cell-cycle transcription in response
to replication stress contributes to two key functions of the
DNA replication checkpoint response, namely, preventing
genomic instability and cell death. Given the critical role of
replication stress in oncogene transformation, a detailed
understanding of the molecular mechanisms involved in the
checkpoint response will contribute to a better insight into
cancer development.
Introduction
To properly replicate the genome and prevent genomic insta-
bility, cells rely on the DNA integrity checkpoints, an evolution-
arily conserved set of signaling pathways that constantly
monitor for the loss of integrity of the DNA replication fork or
DNA damage. The DNA integrity checkpoints are mediated
by the evolutionarily conserved protein kinases ATM/ATR,
acting through Chk1 and Chk2 [1–3]. These protein kinases
transduce the checkpoint signal to the cell-cycle and transcrip-
tional machinery by phosphorylating protein targets [4]. The
DNA replication and DNA damage checkpoints ensure that*Correspondence: r.debruin@ucl.ac.ukDNA has been fully replicated and that damage has been
repaired before division [5]. The fundamental difference be-
tween the two checkpoints is that the DNA replication check-
point is essential for preventing DNA damage in response to
replication stress during S phase, whereas the DNA damage
checkpoint is required to detect and resolve DNA damage
before entry intomitosis.Whereas both checkpoints delay pro-
gression intomitosis via largely overlappingmechanisms, they
induce similar but distinct transcriptional responses [6]. The
differences in mechanism and expression program are poorly
established but are thought to reflect the intrinsically different
aims of the replication and damage checkpoints, to prevent
DNA damage or resolve DNA damage, respectively.
During DNA replication, cells are particularly vulnerable to
genomic instability as replication forks are prone to stall and
collapse when encountering replication blocks or damaged
DNA templates [1, 7]. Replication stress is also a consequence
of oncogene activation. A recent model of oncogenesis pro-
poses that, after oncogene-induced replication stress, DNA
damage ensues, which can lead to a number of mutations in
key tumor suppressors, like TP53, and genomic instability
[8]. It is therefore crucial to understand the cellular response
to replication stress and its role in preventing the occurrence
of DNA damage. The DNA replication checkpoint depends
mainly on ATR and the downstream checkpoint protein kinase
Chk1, although there is some degree of crosstalk with the DNA
damage checkpoint protein kinases ATM and Chk2 [2]. After
phosphorylation by ATR, Chk1 becomes active and is released
from chromatin to phosphorylate its substrates [9], which
include cell-cycle regulators, most notably Cdc25 [10], and
proteins involved in DNA repair, including Rad51 [11].
Whereas the main regulator of DNA-damage-inducible
genes in G1 is the transcription factor p53, a target of both
ATM and Chk2 [12], the molecular details of the largely p53-
independent transcriptional response to replication stress
have not been established [13]. Genome-wide expression
analysis carried out in this study reveals that the G1/S cell-
cycle transcriptional program is regulated as part of the DNA
replication checkpoint response in human cells. In mammalian
cells, G1/S transcriptional regulation depends on the E2F fam-
ily of transcription factors (E2F1–E2F8) and their regulators,
the pocket protein family members (pRb, p107, and p130),
which are well-established tumor suppressors (reviewed in
[14–17]). Previous works established a proapoptotic role for
the activator E2F, E2F1, after DNA damage checkpoint activa-
tion [18–21]. However, this is independent of its role in the cell-
cycle transcriptional program. Here we report a role for the
E2F-dependent cell-cycle transcriptional program in the DNA
replication checkpoint response in human cells. We establish
the mechanism by which the G1/S transcriptional program is
rewired by the DNA replication checkpoint and show that
this regulation is required to cope with replication stress and
avoid genomic instability and cell death. Our study highlights
the inherent difference between the DNA replication and
DNA damage checkpoint responses, showing an intrinsically
different role for E2F-dependent transcription in response to
DNA replication stress: promotion of genome stability and
survival rather than cell death.
Table 1. Enriched Functional Groups of the 846 Genes Induced by HU
Treatment, According to Gene Ontology Analysis
Categories Identified
Number
of Genes % p Value
DNA metabolic process 37 5 6.20 3 10205
DNA repair 22 3 1.30 3 10203
Response to DNA damage stimulus 26 3.5 1.90 3 10203
Deoxynucleotide metabolic process 6 0.8 2.40 3 10203
DNA replication 16 2.2 3.30 3 10203
Defense response 35 4.7 7.30 3 10203
Macromolecular complex subunit
organization
39 5.3 8.00 3 10203
Regulation of apoptosis 43 5.8 8.30 3 10203
Locomotor behavior 19 2.6 9.40 3 10203
Regulation of transcription factor activity 10 1.3 1.10 3 10202
Cell cycle 38 5.1 4.30 3 10202
See also Figure S1 and Table S1.
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Replication Stress Induces E2F-Dependent Cell-Cycle
Transcripts
In order to investigate the DNA replication checkpoint tran-
scriptional response, we analyzed the genome-wide expres-
sion profile of S phase cells with and without replication
stress induced by hydroxyurea (HU) treatment. HU, an inhib-
itor of ribonucleotide reductase, causes nucleotide depletion
and is widely used to induce replication stress [22, 23]. It
causes replication fork stalling after DNA replication origins
have been licensed and fired, resulting in the activation of
the checkpoint protein kinase ATR and its downstream target
Chk1, inducing an intra S phase arrest. Potential cell-cycle
positioning differences after replication stress were avoided
through the use of synchronized human T98G cells. Serum-
starved cells were released in serum for 16 hr (G1/S), at which
point cells were either treated with HU for 4 hr (20 hr HU) or
left untreated for 4 hr (20 hr untreated; experimental design
is represented in Figure S1A available online). The short treat-
ment with HU during S phase induces DNA replication check-
point activation, as detected by S345 phosphorylation of
Chk1 (Figure S1B). Importantly, it does not induce significant
DNA damage, as shown by the low levels of gamma-H2AX
compared to the levels induced by the DNA damaging agent
camptothecin (CPT) at the same time points. Together, these
data show that our experimental setup allows for specific
activation of the DNA replication checkpoint without causing
significant DNA damage and possible DNA damage check-
point activation.
Expression profiles were established by microarray for
untreated and HU-treated samples. Comparison of expression
levels resulted in a list of 846 genes significantly upregulated in
response to HU treatment (Table S1). Gene ontology analysis
of these revealed that the top enriched ontology categories
include the DNA replication, DNA repair, and cell-cycle groups
(Table 1). Since these groups of genes are mainly regulated
during the G1-to-S transition of the cell cycle by the E2F tran-
scription factors, we investigatedwhether therewas an enrich-
ment of E2F target genes among the HU-responsive gene list.
A list of 459 cell-cycle-regulated E2F targets from previous
studies was compiled (Table S2) [24–27]. We find significant
enrichment of E2F targets in the HU-induced gene list (p =
0.035; Figures S1C and S1D and Table S3), suggesting that
E2F-dependent cell-cycle transcription could be part of the
replication stress checkpoint transcriptional response.
To confirm and extend the genome-wide expression anal-
ysis, we carried out single gene expression analysis on a set
of well-established G1/S E2F targets using quantitative PCR
(qPCR). These data show that the well-established G1/S E2F
targets are significantly upregulated during S phase in
response to replication stress (Figure 1A).
E2F-Dependent Cell-Cycle Transcription Is Induced in
Response to Replication Stress in a Chk1-Dependent
Manner
To establish the dynamics of E2F-dependent cell-cycle tran-
scriptional regulation in response to replication stress, we car-
ried out expression analysis in both synchronized (Figures 1B
and S1E) and asynchronous cells (Figure S1G). Expression
levels of the well-established E2F G1/S cell-cycle targets
cyclin E, RRM2, and CDC6 reveal that while transcription is
inactivated in a timely manner in untreated cell cultures, these
transcripts remain active after HU treatment. Similar resultswere obtained with thymidine-induced replication block in
T98G cells (Figure S1F) and in a primary human cell line treated
with HU (Figure S1H). In agreement with the transcriptional
data, the protein levels of cyclin E and E2F1 remain high
upon HU treatment (Figure 1C), while in control cells they
peak at 18–20 hr and then decrease during cell-cycle progres-
sion, as expected.
Since HU treatment causes an intra-S-phase arrest through
Chk1 activation [22, 23, 28], we tested whether the transcrip-
tional response of E2F targets is Chk1 dependent. Chemical
inhibition of Chk1 function by UCN01 treatment shows that
derepression of G1/S transcripts and protein accumulation
of E2F targets in response to HU treatment is Chk1 dependent
(Figures 1B and 1C). Similar results were obtained with small
interfering RNA (siRNA) targeting Chk1 (Figure S1I). Alto-
gether, these results show that E2F-dependent G1/S tran-
scription is maintained at high levels in response to replication
stress via a Chk1-dependent mechanism.
The Transcriptional Repressor E2F6 Binds to E2F-
Regulated Promoters to Inhibit G1/S Transcription
Next we sought to establish the mechanism by which the
checkpoint interferes with G1/S transcription. We hypothe-
sized that the checkpoint could target a transcriptional
repressor normally involved in turning off G1/S transcription
during S phase. A role for E2F6 in timely inactivation of E2F
targets during S phase has been suggested [29]. However,
these studies, carried out in E2F6 knockout mouse fibroblasts,
were inconclusive, likely due to a compensatory role of E2F4
[29]. To establish whether E2F6 could be involved in turning
off transcription during S phase, we first established the bind-
ing of E2F transcription factors to their target genes during the
cell cycle. We carried out a cell-cycle time course of chromatin
immunoprecipitations (ChIP) using antibodies to E2F4, E2F6,
and, as a representative activator E2F, E2F1.
E2F target promoters are mainly occupied by E2F4 in quies-
cence (Figure 2A), as previously reported [30]. Upon release
into the cell cycle, E2F4 is replaced by E2F1, correlating with
transcriptional activation, which, in turn, is replaced by E2F6
once cells progress into S phase. E2F6 recruitment to pro-
moters starts at G1/S and peaks in S phase, when E2F1 is
released, correlating with transcriptional repression, while
E2F4 does not appear to be significantly recruited at this point
(Figure 2A). To determine whether E2F6 plays a role in turning
off G1/S transcription, we analyzed RNA and protein levels of
Figure 1. HU Causes Activation of E2F Transcrip-
tion in a Checkpoint-Dependent Manner
(A) Serum-starved cells were released in serum
with or without HU (2 mM) for 20 hr. RNA levels
of the indicated genes were quantified by qRT-
PCR. Average 6 SD is shown (n = 4). All genes
were significantly induced in HU-treated cells
with p < 0.05.
(B) T98G cells synchronized by serum starvation
were stimulated with serum. Fifteen hours after
serum addition, the cells were either treated with
2 mM HU or left untreated. UCN01 was added to
the indicated samples 30 min before HU addition.
At the indicated time points, cells were collected
and RNA was extracted. Relative RNA abundance
for the indicated genes was evaluated by qRT-
PCR and normalized to actin. Graphs represent
the average 6 SD (n = 3). Black line, HU treated;
gray line, untreated.
(C) Repeat of the experiment in (B). At the indi-
cated time points, proteins were extracted in
RIPA buffer, quantified, and analyzed by western
blot with the indicated antibodies. KU86 is a
loading control. P-Ser345 of Chk1 is shown. The
red box highlights the checkpoint activation; the
green box shows the checkpoint inhibition.
See also Figure S1, Table S1, Table S2, and
Table S3.
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depleted. We observe that acute loss of E2F6, by siRNA
knockdown, leads to a persistently high level of G1/S tran-
scription, relative to control transfected cells. This supports
a role for E2F6 in the repression of E2F targets upon exit
fromG1phase (Figures 2B andS2A). Transcriptional derepres-
sion is also reflected in the sustained high levels of E2F-regu-
lated proteins in the absence of E2F6 (Figures S2B and S2C).
Whereas in control cells these proteins peak at the G1-to-S
transition and then decrease with cell-cycle progression, in
E2F6-depleted cells they remain high. Collectively, these
data suggest that E2F6 plays an important role in repressing
G1/S transcription during G1 and S phases.
E2F6 Repressive Function Is Inhibited in Response to
Replication Stress
E2F6’s function positions it as a potential target via which
the replication checkpoint protein kinase Chk1 could keep
E2F-regulated G1/S transcription active. If inhibition of E2F6
function is part of the DNA replication checkpoint response,
the expression profile of HU-treated and E2F6-depleted cells
should significantly overlap. Genome-wide expressionanalysis using bead microarrays of
synchronized S phase cells either
transfected with siE2F6 or control siRNA
identified more than 700 targets as
significantly induced after E2F6 deple-
tion (Table S4). Gene ontology analysis
revealed enrichment for similar cate-
gories upon HU treatment, among which
the most represented were the DNA
replication and repair and cell-cycle
groups (Table S5). Importantly, there is
a significant overlap (p < 1024) between
the ‘‘siE2F6-upregulated genes’’ and
‘‘HU-upregulated genes’’ (Figure S3 andTable S6), indicating that a common gene set is regulated by
E2F6 and in response to replication stress.
To confirm and extend our genome-wide expression anal-
ysis, we tested whether the E2F cell-cycle targets induced in
response to replication stress (Figure 1A) depend on E2F6
for their repression during S phase. These data show that all
of the 14 well-established E2F-dependent G1/S targets signif-
icantly upregulated in response to HU are also upregulated
in response to E2F6 depletion (Figure 3A), suggesting that
the replication checkpoint could inhibit E2F6-dependent
repression.
We reasoned that one way of inhibiting E2F6 function in
response to replication stress is via affecting its ability to
bind, and repress, E2F target promoters. To test this, we fixed
synchronized T98G cells at the indicated time points and
analyzed the binding of E2F6 and E2F1 at twowell-established
E2F target promoters by ChIP. While E2F6 is recruited to these
promoters when cells enter S phase (20 hr), this recruitment is
significantly reduced in cells treated with HU (Figures 3B and
S4A). Furthermore, the reduced recruitment of E2F6 to these
promoters in response to HU treatment correlates with an
enhanced binding of E2F1 compared to untreated cells. This
Figure 2. E2F6 Binding during S Phase Corre-
lates with G1/S Transcription Repression
(A) Time course of ChIP in starvation-synchro-
nized T98G cells. At the indicated time points
after serum addition, the samples were cross-
linked and processed for ChIP with the reported
antibodies. The relative binding for every time
point was calculated as a percentage of the
highest in each experiment. Graphs represent
average 6 SD (n = 4) of independent experi-
ments. Red boxes highlight peak binding.
(B) T98G cells were transfected in DMEM with
0.1% FCS with the reported siRNA, and after
48–72 hr serum was added. At the indicated
time points, RNA was extracted and the relative
RNA abundance was calculated as previously
described. Average 6 SD is shown (n = 3). Black
lines, E2F6 siRNA; gray lines, control siRNA. Red
boxes mark the times when checkpoint-depen-
dent activation of these transcripts was observed
in Figure 1.
See also Figures S2 and S3 and Table S4 and
Table S5.
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response to nucleotide depletion.
Chk1 Regulates E2F6 through Direct Phosphorylation
Overall, these data indicate that E2F6 could be a direct sub-
strate of Chk1 kinase. An in vitro kinase assay, using immuno-
precipitated E2F6 as a substrate and recombinant Chk1,
confirmed that Chk1 can directly phosphorylate E2F6 in vitro
(Figure 4A). Next we sought to identify the specific E2F6 site(s)
targeted by Chk1. A deletion mutant lacking the first N-termi-
nal 60 amino acids identified that Chk1-dependent phosphor-
ylation of E2F6 ismainly in the first 60 amino acids (Figure S4B).
In the first N-terminal 60 amino acids, two serine residues, Ser
12 and Ser 52, conform to a potential Chk1 consensus (Fig-
ure 4B), and an in vitro kinase assay peptide array identified
both sites as Chk1 targets. Whereas Ser12 appeared to be
the main target site on the basis of in vitro kinase analysis of
the single site mutants, the double-site mutant (E2F6S12/52A)
greatly reduces phosphorylation of the E2F6 protein by Chk1
in vitro (Figure 4C), suggesting that both sites can be targeted
by Chk1. Phosphorylation of Ser12 upon HU treatment was
also identified in vivo by a phospho-Ser12-specific antibody
(Figure 4D) and by mass spectrometric analysis (data not
shown). Inhibition of Chk1 with UCN01 reduces the extent of
E2F6 phosphorylation on Ser12, confirming the role of Chk1
in the regulation of endogenous E2F6 (Figure S4C).
To determine the role of phosphorylation of E2F6 at Ser12/
52 in response to replication stress, we assessed binding of
E2F6 to E2F-regulated promoters and expression of E2F
genes after HU treatment in synchronized cells expressing
either ectopic wild-type E2F6, E2F6S12/52A, or vector alone
(Figure 4E). Maximal binding of wild-type E2F6 to promoters
during S phase is reduced upon HU treatment (Figure 4F), as
previously shown (Figure 3B). However, E2F6S12/52A does not
appear to dissociate from promoters after HU addition,
compared to the untreated samples (Figure 4F). The persis-
tence of E2F6S12/52A at promoters correlates with reduced
expression of E2F transcripts in response to checkpoint acti-
vation (Figure S4D). Altogether, these results indicate that
Chk1 phosphorylates E2F6 at Ser12 and Ser52 to regulate its
function in response to DNA replication stress.Derepressing G1/S Transcription via E2F6 Inactivation
Limits DNA Damage upon Replication Stress
It has been well established that, in response to replication
stress, checkpoint activation is required to stabilize replication
forks [31] and activate othermechanisms to avoid the accumu-
lation of DNA damage [11, 32]. When the checkpoint is
inhibited, either by depletion of Chk1 or by treatment with
inhibitors, increased DNA damage is detected. We therefore
aimed to establish whether the activation of G1/S transcription
was involved in limiting DNA damage in checkpoint-compro-
mised cells exposed to replication stress. We reasoned that
if inactivation of E2F6 by the checkpoint is required to prevent
DNA damage, then ectopic expression of the checkpoint-
insensitive E2F612/52 mutant should increase the extent of
DNAdamage after replication stress. Cells expressing doxycy-
cline-inducible wild-type E2F6 or E2F612/52 were treated with a
low concentration of HU for 24 hr in the presence of doxycy-
cline, and DNA damage was analyzed by western blot with
anti-gamma-H2AX antibodies (Figure 4G). HU alone induces
a barely detectable increase of gamma-H2AX, which could
also be partially explained by the cell synchronization occur-
ring upon HU treatment. Upon HU treatment, cells over-
expressing wild-type E2F6 (2 and 4 mg/ml Doxy) show a slight
increase in gamma-H2AX compared to noninduced conditions
(0 Doxy). Strikingly, the extent of H2AX phosphorylation is
greatly increased by overexpression of the checkpoint-insen-
sitive E2F612/52 mutant (compare lane 9 with lanes 10 and 11),
suggesting that DNAdamage occursmostly when cells cannot
activate a proper transcriptional response to replication
stress. Altogether, these data support a role for checkpoint-
dependent inactivation of E2F6 in preventing DNA damage
after replication stress.
Inactivation of E2F6 Is Important for Cell Survival during
Replication Stress
Our data point to an important role for Chk1 in regulating E2F6-
dependent G1/S transcription. Next we investigated the bio-
logical significance of Chk1’s ability to keepG1/S transcription
on. Since many G1/S genes encode proteins involved in DNA
replication and repair [25, 33], we assessedwhether G1/S tran-
scriptional induction is an important part of the checkpoint
Figure 3. HU Treatment Reduces E2F6 Binding
to Promoters and Upregulates a Group of E2F6-
Regulated Transcripts
(A) T98G cells were transfected in DMEM 0.1%
FCS with the reported siRNA, and after 48–72 hr
serum was added. RNA levels of indicated genes
after 20 hr were quantified by qRT-PCR. Average
6 SD is shown (n = 4). All genes were significantly
induced in siE2F6-treated cells, with p < 0.05.
(B) Synchronized T98G cells were stimulatedwith
serum; at 15 hr, 2 mMHUwas added to half of the
plates. ChIP was performed with the indicated
antibodies. The relative binding for every time
point was calculated as a percentage of the
highest untreated in each experiment. Graphs
represent average 6 SD (n = 3) of independent
experiments. Dark-gray bars, untreated; light-
gray bars, HU treated.
See also Figures S3 and S4 and Table S6.
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inhibition causes cell death due to DNA damage accumulation
during S phase [34, 35]. We reasoned that if Chk1-dependent
inactivation of E2F6 is an important part of the checkpoint
response, knockdown of E2F6 in cells inhibited for Chk1 func-
tion should partially rescue cell death. Synchronized cells
transfected with control or E2F6 siRNA were treated with
Chk1 inhibitor UCN01, HU, or both and were analyzed for cell
viability. We observe that depletion of E2F6 suppresses about
40% of the cell death induced by Chk1 inactivation, as as-
sessed by accumulation of cells with a sub-G1 DNA content
and caspase 3 cleavage (Figures 5A and S5A). This indicates
that inactivation of E2F6 and, thereby, activation of G1/S tran-
scription is important for cell survival in response to replication
stress as a result of checkpoint activation. Based on this, we
reasoned that the opposite, an inability to inactivate E2F6
and activate G1/S transcription, would be detrimental to cells
upon replication stress. To investigate this we analyzed thesurvival of cells where E2F6 was over-
expressed, compromising checkpoint
inactivation, in a clonogenic survival
assay. HEK293 T-Rex cells were treated
with HU for 24 hr in the presence of
various concentrations of doxycycline
to induce E2F6 expression (Figure 5B),
after which they were diluted and
allowed to form colonies. Induction of
E2F6 in these cells strongly reduces
cell survival after HU treatment (Figures
5B and 5C) while increasing the extent
of DNA damage compared to HU alone
(Figure S5B). Collectively, these data
support an important role for inactiva-
tion of E2F6 and thereby activation of
G1/S transcription for cell survival after
replication stress.
Discussion
In this study we show that, in response
to DNA replication stress, the regular
cell-cycle transcriptional program is
maintained at high levels in a Chk1-
dependent manner, and we haveuncovered the mechanisms governing such transcriptional
upregulation. We show that E2F6, a repressor of E2F-depen-
dent G1/S transcription, replaces the activating E2Fs at pro-
moters to repress transcription in cells progressing into S
phase. When cells experience replication stress, the DNA
replication checkpoint kinase Chk1, which is activated by
ATR, phosphorylates E2F6, leading to its dissociation from
promoters. This promotes E2F-dependent transcription,
including that of those genes involved in DNA repair and nucle-
otide synthesis, which mediates cell survival by preventing
genomic instability and cell death.
There might be several reasons to maintain high expression
levels of the cell-cycle transcriptional program in response to
replication stress. For one, many of the genes regulated during
G1/S encode proteins required for DNA replication, including
DNA polymerases and enzymes involved in the production of
dNTPs. One reason for keeping G1/S transcription on during
an intra-S-phase arrest, therefore, might be to maintain the
Figure 4. Chk1-Dependent Phosphorylation of
E2F6 Causes Its Release fromPromoters and Pre-
vents DNA Damage after HU Treatment
(A) In vitro kinase assay (32P) using immunoprecip-
itatedmyc-tagged E2F6 as a substrate and recom-
binant Chk1 or buffer alone as a negative control.
The immunoprecipitatedE2F6wassplit equallybe-
tween the two assay reactions (buffer and Chk1),
and an aliquot was used to check the protein by
western blot (WB) with anti-E2F6 antibodies.
(B) Diagram representing E2F6 protein. The main
domains are highlighted. Asterisks mark Ser12
and Ser52.
(C) In vitro kinase assay (32P), with recombinant
Chk1, of immunoprecipitated HA-tagged wild-
type or mutant E2F6 as a substrate. Western
blot (WB) was performed with the immunoprecip-
itated proteins.
(D) HEK293 cells transfected with HA-E2F6 were
treated with HU (2 mM) for 6 hr or left untreated,
and then E2F6 was immunoprecipitated with an
anti-HA antibody. Western blot was performed
with the indicated antibodies.
(E) Western blot showing the protein levels of
transfected wild-type and mutant (12/52AA)
E2F6 in synchronized T98G cells.
(F) Serum-starved T98G cells were transfected
with pcDNA-E2F6 wild-type or mutant prior to
release in serum for 20 hr, with or without HU
(2 mM). ChIP was performed with anti-HA
antibodies, and the binding to p107 and RAD51
promoters was evaluated by qPCR. The graph
represents the binding upon HU treatment relative
to untreated. Average 6 SD is shown (n = 3).
(G) HEK293 T-Rex cells stably expressing induc-
ible wild-type or mutant E2F6 were treated with
0.5 mM HU for 24 hr in the presence of the indi-
cated concentrations of doxycycline, and then
lysates were prepared and the indicated proteins
were analyzed by western blot.
See also Figure S4.
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checkpoint arrest has been relieved. In addition, many of
the genes of the G1/S transcriptome have important roles
in the stabilization of stalled replication forks and in DNA
repair; hence, their presence is required to prevent genomic
instability. Chk1 itself is encoded by aG1/S gene and, because
the activation of the checkpoint has been reported to increase
Chk1 protein turnover [36], we speculate that enhanced
Chk1 expression could be required to maintain an efficient
checkpoint. Finally, maintaining the expression of genes that
are required for subsequent cell-cycle events, other than
DNA replication, prepares the cell for resuming cell-cycle
progression once the checkpoint is turned off.
This study reveals that the DNA replication checkpoint inter-
feres with the E2F6-dependent negative feedback loop to
maintain high levels of G1/S transcription in response to repli-
cation stress. Other E2F family members might be involved in
the checkpoint transcriptional response. For instance, the
activating E2Fs (E2F1, E2F2, and E2F3) are required for the
expression of E2F target genes and might therefore also be
the target of checkpoint regulation to maintain high levels of
expression. E2F7 and E2F8 have been proposed to inactivate
G1/S transcription during S phase, and recent studies have
shown that the binding of those factors to the E2F1 promoter
is positively regulated by the DNA damage checkpoint in order
to reduce E2F1-dependent apoptosis [37, 38]. Consequently,
depletion or deletion of both E2F7 and E2F8 increases DNA-damage-induced cell death. It is likely that the various E2Fs
involved in G1/S transcription regulation might be affected in
a different way in response to particular forms of stress. This
would allow cells to diversify their response to different stimuli
and to titrate the biological response to the level and nature of
the insult.
Activation of the regular periodic transcriptional program
by replication stress has been demonstrated in Schizosac-
charomyces pombe and in Saccharomyces cerevisiae
[39–41]. However, the E2F family of transcription factors and
their coregulators, the pocket proteins, share no sequence
homology with their yeast counterparts. Remarkably, our
study reveals that the simple yet elegant mechanism by which
checkpoint activation can override the regular periodic tran-
scriptional program is conserved from yeast to humans; the
effector checkpoint protein kinase directly interferes with the
autoregulatory negative feedback loop involved in turning off
G1/S transcription. This illustrates the importance of both the
wiring of these transcriptional networks and the capacity of
those networks to be rewired in cells responding to stress.
A role for the activator E2F, E2F1, in the DNA damage check-
point response has been well established [18–21, 42]. Interest-
ingly, in such studies, DNA damage induces E2F1 activity and
thereby the expression of specific proapoptotic genes. These
targets do not normally have a role in the cell cycle and are not
part of the E2F-dependent cell-cycle transcriptional program.
Furthermore, this mechanism of regulation depends on
Figure 5. Inactivation of E2F6 Enhances Survival of HU-Treated Cells
(A) Synchronized T98G cells transfected with control siRNA or E2F6 siRNA
were treated with HU (2 mM) and UCN01 as indicated for 24–30 hr. Cells
were then collected, stained with propidium iodide, and analyzed by flow
cytometry. SubG1 population was evaluated with FlowJo. Graphs represent
the average 6 SD (n = 3) of independent experiments.
(B) Top: western blot showing E2F6 induction. Bottom: HEK293 T-Rex cells
stably expressing inducible wild-type E2F6 were treated with 0.5 mMHU for
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1635transcriptional induction, while the seemingly modest upregu-
lation of G1/S transcripts in response to replication stress
results from the checkpoint merely maintaining peak expres-
sion by interfering with timely repression, rather than by
inducing transcription. We speculate that since the G1/S
transcriptional network comprises a large number of
dosage-sensitive coregulated genes, this particular mecha-
nism of regulation allows for a controlled high level of expres-
sion within the ‘‘normal’’ range. Therefore, this seemingly
modest upregulation represents the difference between ‘‘on’’
and ‘‘off’’ of G1/S genes expression during the cell cycle,
which is undoubtedly of biological significance. In addition,
our study highlights an inherent difference between the DNA
replication and DNA damage checkpoint responses, showing
an intrinsically different role for E2F1 in response to DNA repli-
cation stress by promoting genome stability and survival
rather than cell death. This emphasizes the contrasts between
the diverse cellular responses to specific genotoxic stresses.
Whereas very toxic DNA damage lesions such as double-
strand breaks can induce a strong apoptotic response,
replication stress causes replication fork stalling, which only
results in DNA damage when forks collapse after prolonged
stress or in the absence of an efficient checkpoint [43].
Therefore, the cellular response to replication stress aims to
stabilize replication forks and prevent DNA damage, at least
temporarily, rather than induce cell death.
We show that E2F6 antagonizes the function of E2F1 and
depletion of E2F6 reduces the toxic effect of Chk1 inactivation,
while overexpression of E2F6 reduces the survival of HU-
treated cells with a concomitant increase in DNA damage.
Collectively, our data support an important role for the expres-
sion of G1/S genes in cells responding to DNA replication
stress, in addition to the well-established role in cell-cycle
progression. They highlight a critical role for this transcrip-
tional response in preventing DNA damage and possible
associated genomic instability, key events in oncogenic trans-
formation. Future research will have to establish which E2F
targets are of particular importance in responding to replica-
tion stress to prevent DNA damage and ensure cell survival.
Experimental Procedures
Cell Culture and Transfection
T98G (p53 mutated) cells (ATCC) were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) with 10% fetal calf serum (FCS) supplemented
with penicillin and streptomycin (Invitrogen). Synchronization was achieved
by 48–72 hr culture in DMEMwith 0.1% FCS and release in DMEMwith 10%
FCS. HU was added as indicated to serum-synchronized cells 15 hr after
release. Transfection of siRNA was performed with Oligofectamine
(Invitrogen).
ChIP and Real-Time PCR
ChIP of synchronized cells was performed as previously reported [30]. RNA
was isolated with the RNeasy kit from QIAGEN, and qRT-PCR was per-
formed with a Eurogentec kit.24 hr in the presence of the indicated concentrations of doxycycline, and
then the cells were washed, diluted, plated on a 10 cm dish, and allowed
to grow for 12–15 days. The cells were then fixed and stained, and colony
density was scored.
(C) Quantification of the colonies of the experiment shown in (B). Histogram
representing the mean 6 SD of three independent experiments. The star
represents significant difference between the non-doxycycline-treated cells
and doxycycline-treated sample in HU. The quantification was performed
with ImageJ.
See also Figure S5.
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HEK293 cells were transfected with pcDNA myc E2F6 [44] or pcDNA3 HA-
E2F6 wild-type [45], the recombinant proteins were purified by immunopre-
cipitation, and the kinase assaywas performed as previously describedwith
recombinant Chk1 (Activemotif).
See the Supplemental Experimental Procedures for additional details.
Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, five figures, and six tables and can be found with this article online
at http://dx.doi.org/10.1016/j.cub.2013.06.063.
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